South Korea
· Delayed Price · Currency is KRW Aptamer Sciences Statistics
Total Valuation
Aptamer Sciences has a market cap or net worth of KRW 32.06 billion. The enterprise value is 25.16 billion.
| Market Cap | 32.06B |
| Enterprise Value | 25.16B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Aptamer Sciences has 29.28 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 29.28M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 17.07% |
| Owned by Institutions (%) | n/a |
| Float | 24.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 64.96 |
| PB Ratio | 1.74 |
| P/TBV Ratio | 3.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.67 |
| EV / Sales | 87.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.96 |
Financial Position
The company has a current ratio of 1.03, with a Debt / Equity ratio of 0.86.
| Current Ratio | 1.03 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.86 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.13 |
| Interest Coverage | -4.02 |
Financial Efficiency
Return on equity (ROE) is -65.13% and return on invested capital (ROIC) is -17.39%.
| Return on Equity (ROE) | -65.13% |
| Return on Assets (ROA) | -11.88% |
| Return on Capital (ROIC) | -17.39% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.01 |
| Inventory Turnover | 2.01 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.98% in the last 52 weeks. The beta is 0.43, so Aptamer Sciences's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -66.98% |
| 50-Day Moving Average | 1,467.06 |
| 200-Day Moving Average | 2,401.16 |
| Relative Strength Index (RSI) | 37.15 |
| Average Volume (20 Days) | 675,141 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aptamer Sciences had revenue of KRW 286.36 million and -9.42 billion in losses. Loss per share was -554.30.
| Revenue | 286.36M |
| Gross Profit | 183.12M |
| Operating Income | -6.46B |
| Pretax Income | -9.42B |
| Net Income | -9.42B |
| EBITDA | -5.84B |
| EBIT | -6.46B |
| Loss Per Share | -554.30 |
Balance Sheet
The company has 16.95 billion in cash and 9.59 billion in debt, giving a net cash position of 7.36 billion or 251.31 per share.
| Cash & Cash Equivalents | 16.95B |
| Total Debt | 9.59B |
| Net Cash | 7.36B |
| Net Cash Per Share | 251.31 |
| Equity (Book Value) | 11.12B |
| Book Value Per Share | 627.68 |
| Working Capital | 473.06M |
Cash Flow
In the last 12 months, operating cash flow was -7.42 billion and capital expenditures -1.08 billion, giving a free cash flow of -8.50 billion.
| Operating Cash Flow | -7.42B |
| Capital Expenditures | -1.08B |
| Free Cash Flow | -8.50B |
| FCF Per Share | -290.37 |
Margins
| Gross Margin | 63.95% |
| Operating Margin | -2,255.90% |
| Pretax Margin | -3,288.10% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Aptamer Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | -0.01% |
| Earnings Yield | -50.62% |
| FCF Yield | -26.52% |
Stock Splits
The last stock split was on February 28, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Feb 28, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Aptamer Sciences has an Altman Z-Score of -2.03. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.03 |
| Piotroski F-Score | n/a |